cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine has been researched along with Cytomegalovirus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, DI; Bourne, N; Bravo, FJ; Schleiss, MR | 1 |
| Bernstein, DI; Bravo, FJ; Cardin, RD | 1 |
| Bernstein, DI; Bourne, N; Bravo, FJ | 1 |
3 other study(ies) available for cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Cytomegalovirus Infections
| Article | Year |
|---|---|
An animal model of neonatal cytomegalovirus infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Guinea Pigs; Liver; Lung; Organophosphorus Compounds; Spleen; Virus Replication | 2003 |
Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Immunity, Maternally-Acquired; Infectious Disease Transmission, Vertical; Organophosphorus Compounds; Pregnancy; Pregnancy Outcome; Virus Replication | 2006 |
Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals.
Topics: Animals; Antiviral Agents; Cyclophosphamide; Cytomegalovirus Infections; Cytosine; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Kidney Function Tests; Liver; Liver Function Tests; Lung; Male; Organophosphorus Compounds; Spleen; Treatment Outcome; Virus Replication | 2000 |